Contract Development and Manufacturing Organization (CDMO) Outsourcing Market by Product and Geography - Global Forecast and Analysis 2019-2023
SKU ID : TNV-14731054 | Publishing Date : 11-Sep-2019 | No. of pages : 136
Detailed TOC of Contract Development and Manufacturing Organization (CDMO) Outsourcing Market by Product and Geography - Global Forecast and Analysis 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Small molecules - Market size and forecast 2018-2023
Biologics - Market size and forecast 2018-2023
Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
APAC - Market size and forecast 2018-2023
South America - Market size and forecast 2018-2023
MEA - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Growing use of analytics by CDMOs
Growing demand for CDMOs for cell and gene therapies
Increasing market consolidation
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Aenova Holding GmbH
Almac Group Ltd.
Catalent Inc.
FAMAR Health Care Services
FAREVA SA
Lonza Group Ltd.
Recipharm AB
Siegfried Holding AG
The Lubrizol Corp.
Thermo Fisher Scientific Inc.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Vendors: Key product offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Small molecules - Market size and forecast 2018-2023 ($ billions)
Exhibit 21: Small molecules - Year-over-year growth 2019-2023 (%)
Exhibit 22: Biologics - Market size and forecast 2018-2023 ($ billions)
Exhibit 23: Biologics - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ billions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ billions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: APAC - Market size and forecast 2018-2023 ($ billions)
Exhibit 33: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 34: South America - Market size and forecast 2018-2023 ($ billions)
Exhibit 35: South America - Year-over-year growth 2019-2023 (%)
Exhibit 36: MEA - Market size and forecast 2018-2023 ($ billions)
Exhibit 37: MEA - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Aenova Holding GmbH - Vendor overview
Exhibit 47: Aenova Holding GmbH – Service segments
Exhibit 48: Aenova Holding GmbH - Organizational developments
Exhibit 49: Aenova Holding GmbH - Key offerings
Exhibit 50: Almac Group Ltd. - Vendor overview
Exhibit 51: Almac Group Ltd. - Product segments
Exhibit 52: Almac Group Ltd. - Organizational developments
Exhibit 53: Almac Group Ltd. - Key offerings
Exhibit 54: Catalent Inc. - Vendor overview
Exhibit 55: Catalent Inc. - Business segments
Exhibit 56: Catalent Inc. - Organizational developments
Exhibit 57: Catalent Inc. - Geographic focus
Exhibit 58: Catalent Inc. - Segment focus
Exhibit 59: Catalent Inc. - Key offerings
Exhibit 60: FAMAR Health Care Services - Vendor overview
Exhibit 61: FAMAR Health Care Services - Service segments
Exhibit 62: FAMAR Health Care Services - Organizational developments
Exhibit 63: FAMAR Health Care Services - Key offerings
Exhibit 64: FAREVA SA - Vendor overview
Exhibit 65: FAREVA SA - Business segments
Exhibit 66: FAREVA SA - Organizational developments
Exhibit 67: FAREVA SA - Key offerings
Exhibit 68: Lonza Group Ltd. - Vendor overview
Exhibit 69: Lonza Group Ltd. - Business segments
Exhibit 70: Lonza Group Ltd. - Organizational developments
Exhibit 71: Lonza Group Ltd. - Geographic focus
Exhibit 72: Lonza Group Ltd. - Segment focus
Exhibit 73: Lonza Group Ltd. - Key offerings
Exhibit 74: Recipharm AB - Vendor overview
Exhibit 75: Recipharm AB - Business segments
Exhibit 76: Recipharm AB - Organizational developments
Exhibit 77: Recipharm AB - Geographic focus
Exhibit 78: Recipharm AB - Segment focus
Exhibit 79: Recipharm AB - Key offerings
Exhibit 80: Siegfried Holding AG - Vendor overview
Exhibit 81: Siegfried Holding AG - Product segments
Exhibit 82: Siegfried Holding AG - Organizational developments
Exhibit 83: Siegfried Holding AG - Segment focus
Exhibit 84: Siegfried Holding AG - Key offerings
Exhibit 85: The Lubrizol Corp. - Vendor overview
Exhibit 86: The Lubrizol Corp. - Business segments
Exhibit 87: The Lubrizol Corp. - Organizational developments
Exhibit 88: The Lubrizol Corp. - Key offerings
Exhibit 89: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 90: Thermo Fisher Scientific Inc. - Business segments
Exhibit 91: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 92: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 93: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 94: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 95: Validation techniques employed for market sizing
Exhibit 96: Definition of market positioning of vendors